These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25212031)

  • 1. [Development of a novel screening assay for inhibitors targeting HIF-1alpha and P300 interaction].
    Lai FF; Niu F; Yang HZ; Zhou WQ; Chen XG
    Yao Xue Xue Bao; 2014 Jun; 49(6):849-53. PubMed ID: 25212031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
    Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
    Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma.
    Viziteu E; Grandmougin C; Goldschmidt H; Seckinger A; Hose D; Klein B; Moreaux J
    Br J Cancer; 2016 Mar; 114(5):519-23. PubMed ID: 26867162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
    Na YR; Han KC; Park H; Yang EG
    Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
    Goey AK; Chau CH; Sissung TM; Cook KM; Venzon DJ; Castro A; Ransom TR; Henrich CJ; McKee TC; McMahon JB; Grkovic T; Cadelis MM; Copp BR; Gustafson KR; Figg WD
    J Nat Prod; 2016 May; 79(5):1267-75. PubMed ID: 27140429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
    Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
    J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.
    Wei J; Yang Y; Lu M; Lei Y; Xu L; Jiang Z; Xu X; Guo X; Zhang X; Sun H; You Q
    Mini Rev Med Chem; 2018; 18(4):296-309. PubMed ID: 27484627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hypoxia-inducible factor-1 alpha radiosensitized MG-63 human osteosarcoma cells in vitro.
    Jin Z; Aixi Y; Baiwen Q; Zonghuan L; Xiang H
    Tumori; 2015; 101(5):578-84. PubMed ID: 26350185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
    Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
    BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-κB suppresses HIF-1α response by competing for P300 binding.
    Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
    Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.
    Cook KM; Hilton ST; Mecinovic J; Motherwell WB; Figg WD; Schofield CJ
    J Biol Chem; 2009 Sep; 284(39):26831-8. PubMed ID: 19589782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction.
    Yang C; Wang W; Li GD; Zhong HJ; Dong ZZ; Wong CY; Kwong DW; Ma DL; Leung CH
    Sci Rep; 2017 Feb; 7():42860. PubMed ID: 28225008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.
    Staab A; Loeffler J; Said HM; Diehlmann D; Katzer A; Beyer M; Fleischer M; Schwab F; Baier K; Einsele H; Flentje M; Vordermark D
    BMC Cancer; 2007 Nov; 7():213. PubMed ID: 17999771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule.
    Kwon HS; Kim DR; Yang EG; Park YK; Ahn HC; Min SJ; Ahn DR
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5249-52. PubMed ID: 22789427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
    Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
    Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
    Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
    Li J; Xi W; Li X; Sun H; Li Y
    Bioorg Med Chem; 2019 Apr; 27(7):1145-1158. PubMed ID: 30819620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
    Yoon H; Lim JH; Cho CH; Huang LE; Park JW
    Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas.
    Lu H; Li Y; Shu M; Tang J; Huang Y; Zhou Y; Liang Y; Yan G
    FEBS J; 2009 Dec; 276(24):7291-304. PubMed ID: 19912340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.